share_log

Virpax Pharmaceuticals Shares Are Trading Higher After Maxim Group Upgraded the Stock From Hold to Buy and Announced a $3 Price Target.

Virpax Pharmaceuticals Shares Are Trading Higher After Maxim Group Upgraded the Stock From Hold to Buy and Announced a $3 Price Target.

維帕克斯藥品的股票因Maxim Group將其升級爲買入並宣佈其股價目標爲3美元而上漲。
Benzinga ·  07/19 11:47

Virpax Pharmaceuticals Shares Are Trading Higher After Maxim Group Upgraded the Stock From Hold to Buy and Announced a $3 Price Target.

維帕克斯藥品的股票因Maxim Group將其升級爲買入並宣佈其股價目標爲3美元而上漲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論